These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19039990)

  • 41. Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
    Stiasny-Kolster K; Oertel WH
    Neuropsychobiology; 2004; 50(1):65-70. PubMed ID: 15179023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RLS patients: who are they?
    Schapira AH
    Eur J Neurol; 2006 Oct; 13 Suppl 3():2-7. PubMed ID: 16930376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ADMET considerations for restless leg syndrome drug treatments.
    de Biase S; Merlino G; Lorenzut S; Valente M; Gigli GL
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1247-61. PubMed ID: 22808933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurocognitive function in patients with idiopathic Restless Legs Syndrome before and after treatment with dopamine-agonist.
    Galbiati A; Marelli S; Giora E; Zucconi M; Oldani A; Ferini-Strambi L
    Int J Psychophysiol; 2015 Mar; 95(3):304-9. PubMed ID: 25514234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Restless legs syndrome: nonpharmacologic and pharmacologic treatments.
    Winkelman JW; Allen RP; Tenzer P; Hening W
    Geriatrics; 2007 Oct; 62(10):13-6. PubMed ID: 17922563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Restless legs syndrome in patients with type 2 diabetes: effectiveness of pramipexole therapy.
    Harashima S; Nishimura A; Osugi T; Wang Y; Liu Y; Takayama H; Inagaki N
    BMJ Support Palliat Care; 2016 Mar; 6(1):89-93. PubMed ID: 25216659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early childhood-onset restless legs syndrome: symptoms and effect of oral iron treatment.
    Tilma J; Tilma K; Norregaard O; Ostergaard JR
    Acta Paediatr; 2013 May; 102(5):e221-6. PubMed ID: 23360128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial.
    Bassetti CL; Bornatico F; Fuhr P; Schwander J; Kallweit U; Mathis J;
    Swiss Med Wkly; 2011; 141():w13274. PubMed ID: 22101745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Severe restless legs syndrome presenting as intractable insomnia.
    Arnulf I; Konofal E; Gauthier C; Chedru F
    Neurology; 2004 Apr; 62(8):E19. PubMed ID: 15111708
    [No Abstract]   [Full Text] [Related]  

  • 50. [Restless legs syndrome in patients with high serum ferritin and normal iron levels].
    Peraita-Adrados R; Duque-Ramírez LG; Vela-Bueno A
    Rev Neurol; 2011 Oct; 53(7):385-9. PubMed ID: 21948008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Increased frequency and spread of restlessness as the early manifestation of Parkinson's disease in a woman with restless legs syndrome].
    Suzuki K; Matsubara T; Miyamoto M; Fujita H; Nakamura T; Hirata K
    Rinsho Shinkeigaku; 2018 Oct; 58(10):617-621. PubMed ID: 30270336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sternberg working memory performance following treatment with pramipexole in patients with moderate-to-severe restless legs syndrome.
    Jung KY; Kim SM; Song JY; Lee BU; Lee C; Lee SK; Koo YS; Cho YW; Choi JW; Kim KH
    Sleep Med; 2015 Jun; 16(6):703-8. PubMed ID: 25934537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of acute dopamine-agonist treatment in restless legs syndrome on heart rate variability during sleep.
    Manconi M; Ferri R; Zucconi M; Clemens S; Rundo F; Oldani A; Ferini-Strambi L
    Sleep Med; 2011 Jan; 12(1):47-55. PubMed ID: 20851046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sleep Disorders: Restless Legs Syndrome.
    Burman D
    FP Essent; 2017 Sep; 460():29-32. PubMed ID: 28845959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
    Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
    Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pediatric restless legs syndrome and periodic limb movement disorder: parent-child pairs.
    Picchietti DL; Rajendran RR; Wilson MP; Picchietti MA
    Sleep Med; 2009 Sep; 10(8):925-31. PubMed ID: 19332386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequent difficulties in the treatment of restless legs syndrome - case report and literature review.
    Narowska D; Bożek M; Krysiak K; Antczak J; Holka-Pokorska J; Jernajczyk W; Wichniak A
    Psychiatr Pol; 2015; 49(5):921-30. PubMed ID: 26688843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Restless legs syndrome: understanding its consequences and the need for better treatment.
    Earley CJ; Silber MH
    Sleep Med; 2010 Oct; 11(9):807-15. PubMed ID: 20817595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Restless legs syndrome: demographics, presentation, and differential diagnosis.
    Hening W; Allen RP; Tenzer P; Winkelman JW
    Geriatrics; 2007 Sep; 62(9):26-9. PubMed ID: 17824723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.